BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15656327)

  • 21. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
    Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
    Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, randomized, controlled, and open study in primarily inoperable, stage III non-small cell lung cancer (NSCLC) patients given sequential radiochemotherapy with or without epoetin alfa.
    Debus J; Drings P; Baurecht W; Angermund R
    Radiother Oncol; 2014 Jul; 112(1):23-9. PubMed ID: 25129551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
    Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH
    J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patients.
    Danova M; Ferrari S
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):21-5. PubMed ID: 12082650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.
    Scott SN; Boeve TJ; McCulloch TM; Fitzpatrick KA; Karnell LH
    Laryngoscope; 2002 Jul; 112(7 Pt 1):1221-9. PubMed ID: 12169903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy.
    Fallowfield L; Gagnon D; Zagari M; Cella D; Bresnahan B; Littlewood TJ; McNulty P; Gorzegno G; Freund M;
    Br J Cancer; 2002 Dec; 87(12):1341-53. PubMed ID: 12454760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
    Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
    J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
    Abdelrazik N; Fouda M
    Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction in transfusion requirements with early epoetin alfa treatment in pediatric patients with solid tumors: a case-control study.
    Kronberger M; Fischmeister G; Poetschger U; Gadner H; Zoubek A
    Pediatr Hematol Oncol; 2002 Mar; 19(2):95-105. PubMed ID: 11881794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of Epoetin alfa on quality of life in anemic cancer patients.
    Cella D; Bron D
    Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
    Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
    Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of managing anemia with and without prophylactic epoetin alfa therapy in breast cancer patients receiving combination chemotherapy.
    Meadowcroft AM; Gilbert CJ; Maravich-May D; Hayward SL
    Am J Health Syst Pharm; 1998 Sep; 55(18):1898-902. PubMed ID: 9784769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
    O'Shaughnessy JA; Vukelja SJ; Holmes FA; Savin M; Jones M; Royall D; George M; Von Hoff D
    Clin Breast Cancer; 2005 Feb; 5(6):439-46. PubMed ID: 15748464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of early intervention with epoetin alfa on transfusion requirement, hemoglobin level and survival during platinum-based chemotherapy: Results of a multicenter randomised controlled trial.
    Savonije JH; van Groeningen CJ; van Bochove A; Honkoop AH; van Felius CL; Wormhoudt LW; Giaccone G
    Eur J Cancer; 2005 Jul; 41(11):1560-9. PubMed ID: 15953714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer.
    Welch RS; James RD; Wilkinson PM; Belli F; Cowan RA
    Cancer J Sci Am; 1995; 1(4):261-6. PubMed ID: 9166486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of epoetin alfa in chemotherapy patients: a consistent profile of efficacy and safety.
    Itri LM
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):81-7. PubMed ID: 12082659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epoetin alfa in patients not on chemotherapy - Canadian data.
    Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F
    Semin Oncol; 2002 Jun; 29(3 Suppl 8):75-80. PubMed ID: 12082658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy.
    Vansteenkiste J; Pirker R; Massuti B; Barata F; Font A; Fiegl M; Siena S; Gateley J; Tomita D; Colowick AB; Musil J;
    J Natl Cancer Inst; 2002 Aug; 94(16):1211-20. PubMed ID: 12189224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epoetin alfa therapy for patients with hematologic malignancies and mild anemia.
    Straus DJ
    Clin Lymphoma; 2003 Aug; 4 Suppl 1():S13-7. PubMed ID: 14556671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.